Acute Liver Failure Induced by Sorafenib Combined with Diclofenac Sodium: A Case Report

Yue Yin, Yu-Pei Wu, X. Deng, L. Bai, Qing-Xia Li
{"title":"Acute Liver Failure Induced by Sorafenib Combined with Diclofenac Sodium: A Case Report","authors":"Yue Yin, Yu-Pei Wu, X. Deng, L. Bai, Qing-Xia Li","doi":"10.4172/2161-0495.1000407","DOIUrl":null,"url":null,"abstract":"Introduction: Drug-induced liver injury is one of the most common adverse drug reactions in clinical. Sorafenib is a widely used in hepatoma patients, while diclofenac sodium in patients suffering from cancer pain. Both of the two drugs showed mild and unfrequented liver damage. However, taking both drugs orally at the same time may cause severe liver function abnormity and there are few reports at present. Case report: We'll expatiate on an unusual case of a patient with kidney cancer who takes sorafenib and diclofenac sodium simultaneously and suffered from severe and acute liver failure about nearly two months. Conclusion: Sorafenib and diclofenac are likely to have some interactions. Clinically, the combination of the two should be carefully considered to reduce the potential risk of liver damage and avoid liver failure or even liver necrosis.","PeriodicalId":15433,"journal":{"name":"Journal of Clinical Toxicology","volume":"23 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2161-0495.1000407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Drug-induced liver injury is one of the most common adverse drug reactions in clinical. Sorafenib is a widely used in hepatoma patients, while diclofenac sodium in patients suffering from cancer pain. Both of the two drugs showed mild and unfrequented liver damage. However, taking both drugs orally at the same time may cause severe liver function abnormity and there are few reports at present. Case report: We'll expatiate on an unusual case of a patient with kidney cancer who takes sorafenib and diclofenac sodium simultaneously and suffered from severe and acute liver failure about nearly two months. Conclusion: Sorafenib and diclofenac are likely to have some interactions. Clinically, the combination of the two should be carefully considered to reduce the potential risk of liver damage and avoid liver failure or even liver necrosis.
索拉非尼联合双氯芬酸钠致急性肝衰竭1例
前言:药物性肝损伤是临床最常见的药物不良反应之一。索拉非尼是一种广泛用于肝癌患者的药物,而双氯芬酸钠则用于癌症疼痛患者。这两种药物均表现出轻微且罕见的肝损伤。但同时口服两种药物可引起严重的肝功能异常,目前鲜有报道。病例报告:我们将详细介绍一个罕见的病例,肾癌患者同时服用索拉非尼和双氯芬酸钠,近两个月出现严重急性肝功能衰竭。结论:索拉非尼与双氯芬酸可能存在相互作用。临床上应慎重考虑两者联合使用,以降低肝损害的潜在风险,避免肝功能衰竭甚至肝坏死。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信